Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/2018
The semi-annual review summarize the important events, including M&A,JV licensing & R&D partnership deals, new drug R&D projects and new regulations, reco... (8/9/2018)
   
Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery (8/14/2018)
SCMP: Fierce Competition in China's Nascent Immuno-therapy Cancer Drugs Market Could Compromise Safety (8/14/2018)
China National Drug Administration Sets Guidelines for Overseas Drug Trial Data (8/14/2018)
Big Pharma Opportunities Aplenty in China (8/14/2018)
Cross-Border Funding in the Life Sciences (8/9/2018)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/2018 (8/9/2018)
China Braces for More Pain from Trade War as Economy Slows (8/6/2018)
China-related Drug Scandals Showcase Risks in Global Supply Chains (8/6/2018)
China Ups Pressure on MNCs in the Wake of Intriguing Film about Smuggled Life-saving Anticancers (8/3/2018)
China Isn't Yet Ready to Conduct Clinical Trials for The Pharma Industry (8/3/2018)
How China's Protectionist Vaccine Policy Has Backfired on Beijing (7/31/2018)
BT: Another Chinese Pharma Billionaire But Where's the Profit? (7/31/2018)
A Solution to China's Pharma Woes Might Be a Blockchain Away (7/31/2018)
The Diabetes Market in China (7/24/2018)
SCMP: China's Vaccination System Has Been Crippled by Corruption, Weak Regulations And Staff Shortages (7/24/2018)
CDE Solicits Comments of Draft Guideline...  (8/17/2018)
Recent Executive Moves  (8/17/2018)
Adlai Nortye Opens R&D Site in Bosto...  (8/17/2018) (free)
Top Drug Regulators and Senior Local Off...  (8/16/2018)
China Grand Given More Time for Acquisit...  (8/16/2018)
Trump Lashes Out on China and Mexico for...  (8/16/2018)
CNDA Approves Hengrui’s Breast Cancer D...  (8/16/2018)
Kintor and Frontier Reportedly Seeking I...  (8/16/2018)
Gilead's Key Sovaldi Patent Claims Parti...  (8/16/2018)
Indian Drugmakers Hit by Rising Prices o...  (8/16/2018)
Chinese Pharma Growth Continues to Slow ...  (8/16/2018)
Chinese Online Drugstore 111 Inc. Files ...  (8/15/2018)
Blackstone Invests $400M in YiChang HEC ...  (8/15/2018)
CANbridge Approved to Commence CAN017 Ib...  (8/14/2018) (free)
FDA Warns Four Manufacturers from China,...  (8/14/2018)
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA...
SMEI: Chinese Drug Terminal Market Up 6.9% in H1
IQVIA: Overview of the Chinese Pharmaceutical Market in 2017
Nicholas Hall Reports MAT Q1/2018 Data on the Global OTC / Chin...
New Report: China's CDMO Market to Boom by 2021
IQVia: Overview of Urban Chinese Hospital Drug Sales in 2017
Adlai Nortye Opens R&D Site in Boston
China Grand Given More Time for Acquisition Offer to Sinclai...
CNDA Approves Hengrui’s Breast Cancer Drug Pyrotinib Condit...
Kintor and Frontier Reportedly Seeking IPOs in Hong Kong
Chinese Pharma Growth Continues to Slow as Shares of Online ...
CDE Solicits Comments of Draft Guidelines for Aluminum A...
Chinese Pharmacopoeia Commission Announces Proposed Addi...
CDE Publicizes Batch 31 of Drug Applications To Be Grant...
CDE Solicits Comments on List of Urgently-needed New Dru...
NHC Investigating A New Vaccine Case Involving Expired V...
Trump Lashes Out on China and Mexico for Opioid and Fentanyl...
Gilead's Key Sovaldi Patent Claims Partially Invalidated in ...
China To Establish More Intellectual Property Protection Cen...
Shanghai AIC Officially Terminates Antimonopoly Investigatio...
MSF Challenges Gilead's Chinese Patent HCV Drug Velpatasvir
Indian Drugmakers Hit by Rising Prices of Chinese Interm...
FDA Warns Four Manufacturers from China, India and Canad...
WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspect...
Medicines Containing Huahai's Valsartan API Recalled in ...
EMA Reviewing and Recalling Medicines Containing Valsart...
CANbridge Approved to Commence CAN017 Ib/III Trial for E...
Sihuan Pharma's Self-Developed Anticancer Pirotinib Comm...
CBT Pharma Gets Ethics Approval for APOLLO-1 Phase 1/2 T...
Nobel Laureate to Launch Biomedicine Laboratory in Shenz...
Clover Biopharma Initiates Phase I Study of Etanercept B...
NHC and SATCM Issue Notice for Building of Tiered Medica...
State Council Issues Notice to Divide Fiscal Responsibil...
SMIA Official: BMI Negotiation for 18 Anticancers To Be ...
State Council Issues New Guideline to Enhance Medical Se...
NHC Drafts Document to Improve the National Essential Dr...
Recent Executive Moves
Top Drug Regulators and Senior Local Officials Punished ov...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: World Congress on Virology 2018
Upcoming Event: GUT Health Congress Asia 2018
Upcoming Event: 5th World Congress on Epigenetics and Ch...
Upcoming Event: 7th International Conference on Neurolog...
Upcoming Event: Shanghai eHealth Workshop
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links